Archer Materials

Business news, market intelligence, and global industry analysis.

The Latest

Debenhams Group returns to growth as $DEBS investors assess marketplace strategy and profit recovery

Flexential appoints Sam Rudek as COO to scale high-density data center operations

Flexential brings in Sam Rudek as COO amid nationwide AI infrastructure buildout

ACME Solar QIP puts #ACMESOLAR in focus as Rs 2,800cr raise strengthens renewable growth funding

Representative image of Paladin Energy’s uranium mining and exploration operations, reflecting its dual-hemisphere strategy spanning Namibia’s Langer Heinrich and Canada’s Patterson Lake South projects.

Uranium Energy Corp (NYSE American: UEC) and the nuclear bet powering the AI grid

Archer Materials (AXE) advances Biochip to beta prototype as silicon-first strategy targets clinical validation

Archer Materials (ASX: AXE) advances its Biochip medical diagnostic to beta prototype, targeting clinical trials via silicon-first strategy and Stage 2 imec partnership. Read the full analysis.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

April 7, 2026